Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Corsini

Showing results (61-70 of 200) with videos related to

Pageof 20
Sort By:
Kardiologia Polska|July 28, 2020
Statins plus ezetimibe in the era of proprotein convertase subtilisin/ kexin type 9 inhibitorsLeonardo De Luca, Alberto Corsini, Massimo Uguccioni, et al.
Pharmacological Research|December 31, 2017
Present therapeutic role of cholesteryl ester transfer protein inhibitorsNicola Ferri, Alberto Corsini, Cesare R Sirtori, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 12, 2020
Proprotein convertase subtilisin/kexin type 9: an update on the cardiovascular outcome studiesNicola Ferri, Maria Francesca Grego, Alberto Corsini, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|November 20, 2025
The role of the PPAR system in diabetic cardiovascular risk and beyondMassimiliano Ruscica, Chiara Macchi, Alberto Corsini, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|October 15, 2021
New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiranMassimiliano Ruscica, Cesare Riccardo Sirtori, Nicola Ferri, et al.
Expert Opinion on Biological Therapy|May 30, 2017
Bococizumab for the treatment of hypercholesterolaemiaNicola Ferri, Alberto Corsini, Cesare R Sirtori, et al.
Journal of Cardiovascular Pharmacology|August 8, 2013
Role of small GTPase protein Rac1 in cardiovascular diseases: development of new selective pharmacological inhibitorsNicola Ferri, Alessandro Contini, Sergio Kevin Bernini, et al.
Atherosclerosis|August 13, 2019
PCSK9 inhibition and inflammation: A narrative reviewMassimiliano Ruscica, Lale Tokgözoğlu, Alberto Corsini, et al.
Pharmaceutics|June 24, 2022
Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical PracticeNicola Ferri, Elisa Colombo, Marco Tenconi, et al.
Journal of Medicinal Chemistry|June 17, 2009
Virtual screening approach for the identification of new Rac1 inhibitorsNicola Ferri, Alberto Corsini, Paolo Bottino, et al.
Pageof 20

Showing results (61-70 of 200) with videos related to

Sort By:
Pageof 20
Kardiologia Polska|July 28, 2020
Statins plus ezetimibe in the era of proprotein convertase subtilisin/ kexin type 9 inhibitorsLeonardo De Luca, Alberto Corsini, Massimo Uguccioni, et al.
Pharmacological Research|December 31, 2017
Present therapeutic role of cholesteryl ester transfer protein inhibitorsNicola Ferri, Alberto Corsini, Cesare R Sirtori, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 12, 2020
Proprotein convertase subtilisin/kexin type 9: an update on the cardiovascular outcome studiesNicola Ferri, Maria Francesca Grego, Alberto Corsini, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|November 20, 2025
The role of the PPAR system in diabetic cardiovascular risk and beyondMassimiliano Ruscica, Chiara Macchi, Alberto Corsini, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|October 15, 2021
New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiranMassimiliano Ruscica, Cesare Riccardo Sirtori, Nicola Ferri, et al.
Expert Opinion on Biological Therapy|May 30, 2017
Bococizumab for the treatment of hypercholesterolaemiaNicola Ferri, Alberto Corsini, Cesare R Sirtori, et al.
Journal of Cardiovascular Pharmacology|August 8, 2013
Role of small GTPase protein Rac1 in cardiovascular diseases: development of new selective pharmacological inhibitorsNicola Ferri, Alessandro Contini, Sergio Kevin Bernini, et al.
Atherosclerosis|August 13, 2019
PCSK9 inhibition and inflammation: A narrative reviewMassimiliano Ruscica, Lale Tokgözoğlu, Alberto Corsini, et al.
Pharmaceutics|June 24, 2022
Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical PracticeNicola Ferri, Elisa Colombo, Marco Tenconi, et al.
Journal of Medicinal Chemistry|June 17, 2009
Virtual screening approach for the identification of new Rac1 inhibitorsNicola Ferri, Alberto Corsini, Paolo Bottino, et al.
Pageof 20